Carregant...
Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives
Non-small cell lung cancer (NSCLC) still constitutes the most common cancer-related cause of death worldwide. All efforts to introduce suitable treatment options using chemotherapeutics or targeted therapies have, up to this point, failed to exhibit a substantial effect on the 5-year-survival rate....
Guardat en:
| Publicat a: | Epigenetics |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5193491/ https://ncbi.nlm.nih.gov/pubmed/27846368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2016.1237345 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|